Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder

about

Mastocytosis: from a Molecular Point of View.How we diagnose and treat systemic mastocytosis in adults.A variant c-KIT mutation, D816H, fundamental to the sequential development of an ovarian mixed germ cell tumor and systemic mastocytosis with chronic myelomonocytic leukemia.

P2860

Q39446801-EA244AF0-DF14-4044-A88E-5C6998C0120D Q47763014-5A0297EB-BD9D-4808-AFF0-44E99A39987A Q51363110-7503A7C7-E402-40BF-AE80-4ADE92FC711A

P2860

Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder

Item

http://www.wikidata.org/entity/Q36210845

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder

@ast

Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder

@en

type

Item

label

Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder

@ast

Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder

@en

prefLabel

Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder

@ast

Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder

@en

P1476

Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder

@en

P2093

Anindya Chatterjee

http://www.w3.org/2001/XMLSchema#string

Joydeep Ghosh

http://www.w3.org/2001/XMLSchema#string

Reuben Kapur

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells

Mast cell homeostasis and the JAK-STAT pathway

c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosis

Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene

KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation

Mutation D816V alters the internal structure and dynamics of c-KIT receptor cytoplasmic region: implications for dimerization and activation mechanisms

Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies

P304

18250-18264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.18632/ONCOTARGET.4213

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2015-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279966707

http://www.w3.org/2001/XMLSchema#string

P698

26158763

http://www.w3.org/2001/XMLSchema#string

P921

mastocytosis

myeloproliferative disorders

cell surface receptor

genetic variation

membrane proteins

proto-oncogene proteins

neoplasm proteins

Anzim

P932

4621888

http://www.w3.org/2001/XMLSchema#string

Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder

about

P2860

P2860

Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P5008

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P5008

P577

P5875

P698

P921

P932